Podocyte–actin dynamics in health and disease

L Perico, S Conti, A Benigni, G Remuzzi - Nature Reviews Nephrology, 2016 - nature.com
Genetic studies of hereditary forms of nephrotic syndrome have identified several proteins
that are involved in regulating the permselective properties of the glomerular filtration …

New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome

M van Husen, MJ Kemper - Pediatric nephrology, 2011 - Springer
Although many children with idiopathic nephrotic syndrome (INS) respond initially to steroid
therapy, repeated courses for patients with relapses often cause significant steroid toxicity …

Biologics in steroid resistant nephrotic syndrome in childhood: review and new hypothesis-driven treatment

A Angeletti, M Bruschi, X Kajana, E La Porta… - Frontiers in …, 2023 - frontiersin.org
Nephrotic syndrome affects about 2–7 per 100,000 children yearly and accounts for less
than 15% of end stage kidney disease. Steroids still represent the cornerstone of therapy …

Rituximab treatment for relapsing minimal change disease and focal segmental glomerulosclerosis: a systematic review

A Kronbichler, J Kerschbaum… - American journal of …, 2014 - karger.com
Background: Minimal change disease (MCD) and focal segmental glomerulosclerosis
(FSGS) remain a therapeutic challenge, since steroids and other immunosuppressive …

High-dose rituximab ineffective for focal segmental glomerulosclerosis: a long-term observation study

D Roccatello, S Sciascia, D Rossi, M Alpa… - American Journal of …, 2017 - karger.com
Background: A beneficial effect of rituximab (RTX) on focal segmental glomerulosclerosis
(FSGS) in pediatric patients or in transplant recipients has been reported in isolated cases …

[HTML][HTML] Human adipose tissue− derived mesenchymal stem cells facilitate the immunosuppressive effect of cyclosporin A on T lymphocytes through Jagged-1 …

D Shi, L Liao, B Zhang, R Liu, X Dou, J Li, X Zhu… - Experimental …, 2011 - Elsevier
OBJECTIVE: Cyclosporine A (CsA), known as an effective immunosuppressive agent, is
widely used in clinical fields. Mesenchymal stem cells may exert immunomodulatory effects …

Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis

Y Hamasaki, N Yoshikawa, H Nakazato, S Sasaki… - Pediatric …, 2013 - Springer
Background Cyclosporine has improved remission rates in children with steroid-resistant
nephrotic syndrome (SRNS). However, little prospective long-term follow-up data is …

Inducible ATF3–NFAT axis aggravates podocyte injury

H Zhang, S Liang, Y Du, R Li, C He, W Wang… - Journal of Molecular …, 2018 - Springer
Podocyte injury and loss contribute to proteinuria, glomerulosclerosis, and eventually kidney
failure. Activating transcription factor 3 (ATF3) is a stress inducible transcription factor that is …

Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial

H Ren, P Shen, X Li, X Pan, W Zhang… - American Journal of …, 2013 - karger.com
Background: The efficacy and safety of tacrolimus (TAC) and cyclophosphamide (CTX) were
prospectively examined in steroid-dependent or steroid-resistant primary focal segmental …

CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent‐Relapse Minimal Change Disease

YM Teh, SK Lim, N Jusoh, K Osman… - BioMed Research …, 2021 - Wiley Online Library
Minimal change disease (MCD) is the most common cause of idiopathic nephrotic syndrome
in children, and it is well known for its multifactorial causes which are the manifestation of the …